How Avio Medtech Fast-Tracked QMS Readiness with Grand Avenue Software

Partner

Avio Medtech Consulting

Client

Neuromodulatory medical device startup

Challenge

No existing QMS; needed audit-ready system for rapid FDA approval

Solution

Startup implemented Grand Avenue Software with Avio Medtech’s quality leadership guidance

Results

Achieved ISO 13485 certification, passed 4 audits, and secured FDA approval for two 510(k) submissions

Partner: Avio Medtech Consulting
Client: Neuromodulatory medical device startup
Challenge: No existing QMS; needed audit-ready system for rapid FDA approval
Solution: Startup implemented Grand Avenue Software with Avio Medtech’s quality leadership guidance
Results: Achieved ISO 13485 certification, passed 4 audits, and secured FDA approval for two 510(k) submissions

Avio Medtech is a consulting firm that supports early-stage medical device companies. In this project, Avio provided fractional quality implementation services for their client, offering full-time expertise at a startup-friendly budget. Avio helps startups establish robust, compliant, and scalable QMS frameworks tailored to their growth stage, budget, and regulatory pathway.

Avio Medtech partnered with an early-stage startup developing an innovative neuromodulation device. With a strong clinical concept and plans to enter both FDA and MDSAP markets, the team needed a strategic partner to help establish a compliant, scalable quality system from the ground up.

Avio brought their deep expertise in startup QMS implementation to support the client through each stage of development—from initial planning to regulatory readiness.

The client faced steep regulatory demands but lacked the foundational systems to meet them. Key challenges included:

  • No Existing QMS: The team had no paper or electronic system in place to manage documentation or compliance activities.
  • Budget Constraints: Like many early-stage startups, the client needed a cost-effective approach that didn’t sacrifice compliance.
  • Audit Pressure: The startup would soon face audits from ISO and MDSAP bodies and needed to quickly implement a validated system.

Avio Medtech selected Grand Avenue Software as the ideal platform to launch and grow the startup’s quality system. They started with document control and training modules—then gradually expanded the system to include:

This modular growth strategy allowed the startup to delay certain costs until needed, without ever needing to switch systems.

Avio took a hands-on role in the implementation—acting as a fractional extension of the startup’s internal team. Key steps included:

  • Configuring Workflows: Tailored document version control, change requests, and impact tracking to meet FDA and ISO requirements.
  • Migrating Paper Records: Imported legacy documents and linked them to new Grand Avenue modules for easy traceability.
  • Training & Onboarding: Used intuitive demos and micro-guides to train team members gradually—ensuring adoption across departments.
  • Process Impact Automation: Implemented logic to flag changes that require supplier notifications, notified body reporting, or validation activities.

This hands-on implementation model allowed the team to hit the ground running, even with no prior QMS infrastructure in place.

With Avio Medtech’s guidance and Grand Avenue’s intuitive platform, the client:

  • Passed 4 Consecutive Audits: Including audits by SGS North America for ISO 13485 and MDSAP compliance.
  • Achieved FDA Approval: Two successful 510(k) submissions, with documentation managed entirely in Grand Avenue.
  • Improved Audit Readiness: Centralized access to Design History Files, supplier evaluations, and process change records.
  • Reduced Administrative Burden: Legacy paper records were organized and cross-referenced, streamlining audit prep and internal reviews.

Avio continues to support the client as they scale for commercialization—confident in the flexibility and compliance of their QMS foundation.

For early-stage startups, launching a compliant QMS can feel overwhelming. By combining fractional quality leadership with Grand Avenue Software’s scalable platform, Avio Medtech helps clients achieve regulatory success without the burden of unnecessary overhead or system bloat.

Today, this neuromodulatory startup is equipped to expand into new markets, backed by a eQMS designed to scale with them.

An early-stage neuromodulatory medical device startup with no existing QMS implemented Grand Avenue Software with guidance from Avio Medtech Consulting. Avio provided fractional quality leadership — giving the startup full-time expertise at a startup-friendly budget — while Grand Avenue served as the eQMS platform. The startup achieved ISO 13485 certification, passed four audits, and secured FDA approval for two 510(k) submissions.

Yes. The startup in the Avio MedTech case study had no existing QMS when they began working with Avio and Grand Avenue Software. Despite starting from zero, they achieved ISO 13485 certification, passed four audits, and received FDA approval for two 510(k) submissions. Grand Avenue’s out-of-the-box compliance and straightforward implementation made it possible to establish a fully audit-ready quality system within a timeline compatible with active regulatory submissions.

Fractional quality leadership gives early-stage medical device companies access to experienced quality professionals on a part-time or project basis, rather than hiring a full-time quality team. In the Avio MedTech case study, Avio provided fractional quality implementation services while using Grand Avenue Software as the underlying eQMS platform — allowing the startup to build a compliant, audit-ready quality system without the overhead of a full internal quality department.